Dysregulation of BAs → 1Inhibited CD80/CD86 expression on DCs; 2Induced ROS accumulation; 3Limited the energy supply of TME → CAR-T/TCR-T cell exhaustion → HCC drug resistance. Here, CD86 is linked to hepatocellular carcinoma.